Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model
(opens in new window)
Author(s):
Frederick W. Thielen, Hedwig M. Blommestein, Liesbeth E.M. Oosten, Friso G. Calkoen, Arjan C. Lankester, Jaap J. Zwaginga, Katarina Le Blanc, Alba Redondo, Fermin Sánchez-Guijo, Mattia Algeri, Franco Locatelli, Wim E. Fibbe, Carin A. Uyl-de Groot
Published in:
European Journal of Haematology, Issue 101/5, 2018, Page(s) 676-683, ISSN 0902-4441
Publisher:
Blackwell Publishing Inc.
DOI:
10.1111/ejh.13158
Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization
(opens in new window)
Author(s):
Koen Schepers, Willem E. Fibbe
Published in:
Annals of the New York Academy of Sciences, Issue 1370/1, 2016, Page(s) 15-23, ISSN 0077-8923
Publisher:
New York Academy of Sciences
DOI:
10.1111/nyas.12984